Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Jan 08, 2016 10:06am
165 Views
Post# 24439841

RE:RE:CANADA's M AND A 2015 FYI

RE:RE:CANADA's M AND A 2015 FYIGood perspective narmac.

I do tend to agree with some of your thoughts although I see no point at all in trash talk. If Yahoo is into that then to me it's like typical American trash talk TV and that has zero value to me. I won't be dragged down to that level in my life because it is pointless.

I do post on SH when I have thoughts that will not be accepted at Agoracom so I understand where you are coming from. However, I hope that I never attack another poster and that I never trash talk.

I've been very positive on the RVX science and more skeptical about the business and shareholder value side and I am becoming more skeptical of Don and the business side (that is something I cannot say on Agoracom). 

My intent in posting has always been to collect my own thoughts and the reason I read posts is develop new perspectives. I've never intended to pump.

To me the most important poster by far is BDAZ because he/she seems to truly have the best understanding of the science. Tundup was also an exteremely valuable poster because of the breadth of investment knowledge he/she brought.

Anyway, all the best for 2016. I don't there will be any money made out of RVX for a few years IMHO.

Toinv
Bullboard Posts